PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 211 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $20,584,000 | +162.6% | 1,144,217 | +4.1% | 0.00% | +100.0% |
| Q1 2020 | $7,838,000 | -83.9% | 1,099,410 | -46.2% | 0.00% | -60.0% |
| Q4 2019 | $48,822,000 | +92.6% | 2,044,534 | +116.3% | 0.01% | -16.7% |
| Q3 2019 | $25,347,000 | +7.2% | 945,108 | +8.5% | 0.01% | 0.0% |
| Q2 2019 | $23,641,000 | -15.4% | 871,425 | +8.1% | 0.01% | -14.3% |
| Q1 2019 | $27,959,000 | -1.9% | 805,759 | -44.8% | 0.01% | +75.0% |
| Q4 2018 | $28,508,000 | +53.7% | 1,460,498 | +109.7% | 0.00% | -20.0% |
| Q3 2018 | $18,548,000 | -26.3% | 696,515 | +4.6% | 0.01% | -37.5% |
| Q2 2018 | $25,151,000 | +29.5% | 665,910 | +12.0% | 0.01% | +33.3% |
| Q1 2018 | $19,422,000 | -35.7% | 594,676 | -4.2% | 0.01% | -40.0% |
| Q4 2017 | $30,226,000 | -2.9% | 620,913 | +7.7% | 0.01% | -9.1% |
| Q3 2017 | $31,137,000 | +13.4% | 576,301 | +17.9% | 0.01% | 0.0% |
| Q2 2017 | $27,448,000 | +45.4% | 488,678 | +1.4% | 0.01% | +37.5% |
| Q1 2017 | $18,879,000 | +91.1% | 481,732 | +9.4% | 0.01% | +60.0% |
| Q4 2016 | $9,878,000 | +5.3% | 440,208 | +6.6% | 0.01% | 0.0% |
| Q3 2016 | $9,379,000 | -3.8% | 413,001 | -0.0% | 0.01% | 0.0% |
| Q2 2016 | $9,747,000 | +19.8% | 413,060 | +3.6% | 0.01% | +25.0% |
| Q1 2016 | $8,137,000 | -60.8% | 398,879 | -1.1% | 0.00% | -66.7% |
| Q4 2015 | $20,758,000 | +35.6% | 403,476 | +12.3% | 0.01% | +33.3% |
| Q3 2015 | $15,311,000 | -4.7% | 359,245 | +1.9% | 0.01% | 0.0% |
| Q2 2015 | $16,063,000 | +24.0% | 352,648 | +3.3% | 0.01% | +28.6% |
| Q1 2015 | $12,959,000 | +50.4% | 341,392 | +12.2% | 0.01% | +40.0% |
| Q4 2014 | $8,619,000 | +28.3% | 304,376 | +14.5% | 0.01% | +25.0% |
| Q3 2014 | $6,718,000 | +188.4% | 265,765 | +232.9% | 0.00% | +100.0% |
| Q2 2014 | $2,329,000 | +49.1% | 79,844 | +32.3% | 0.00% | +100.0% |
| Q1 2014 | $1,562,000 | +27.9% | 60,331 | +27.2% | 0.00% | 0.0% |
| Q4 2013 | $1,221,000 | +0.9% | 47,447 | +4.9% | 0.00% | 0.0% |
| Q3 2013 | $1,210,000 | +162.5% | 45,222 | +141.0% | 0.00% | – |
| Q2 2013 | $461,000 | – | 18,764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,220,672 | $55,602,000 | 9.30% |
| Fernwood Investment Management, LLC | 201,211 | $9,165,000 | 7.20% |
| Cormorant Asset Management, LP | 500,000 | $22,775,000 | 3.03% |
| Ghost Tree Capital, LLC | 170,000 | $7,744,000 | 2.51% |
| HARVEY CAPITAL MANAGEMENT INC | 155,030 | $7,108,000 | 2.40% |
| SECTORAL ASSET MANAGEMENT INC | 1,169,130 | $53,254,000 | 2.22% |
| Atika Capital Management LLC | 98,000 | $4,464,000 | 2.01% |
| Temasek Holdings (Private) Ltd | 5,833,568 | $265,719,000 | 1.66% |
| CABOT WEALTH MANAGEMENT INC | 124,309 | $5,662,000 | 1.38% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 314,689 | $14,334,000 | 1.11% |